149 related articles for article (PubMed ID: 18785096)
1. [To the point].
Wildner M
Gesundheitswesen; 2008; 70(8-9):517-8. PubMed ID: 18785096
[No Abstract] [Full Text] [Related]
2. What are open-label extension studies for?
Taylor WJ; Weatherall M
J Rheumatol; 2006 Apr; 33(4):642-3. PubMed ID: 16583468
[No Abstract] [Full Text] [Related]
3. How to get the answer to nearly everything: using the internet for epilepsy research.
Bergin P; Frith R; Walker E; Timmings P
Epilepsia; 2007 Jul; 48(7):1415-7; discussion 1417-24. PubMed ID: 17635559
[No Abstract] [Full Text] [Related]
4. Planning a randomized trial.
Ranstam J
Acta Radiol; 2008 Oct; 49(8):893-4. PubMed ID: 18608008
[No Abstract] [Full Text] [Related]
5. Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies.
Nallamothu BK; Hayward RA; Bates ER
Circulation; 2008 Sep; 118(12):1294-303. PubMed ID: 18794402
[No Abstract] [Full Text] [Related]
6. Randomized controlled experiments in health and social sciences: some conceptual issues.
Bhargava A
Econ Hum Biol; 2008 Jul; 6(2):293-8. PubMed ID: 18325858
[TBL] [Abstract][Full Text] [Related]
7. Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations.
Bradbury BD; Brookhart MA; Winkelmayer WC; Critchlow CW; Kilpatrick RD; Joffe MM; Feldman HI; Acquavella JF; Wang O; Rothman KJ
Am J Kidney Dis; 2009 Sep; 54(3):554-60. PubMed ID: 19592144
[TBL] [Abstract][Full Text] [Related]
8. Research in general practice in New Zealand.
Reid J
N Z Med J; 2003 Nov; 116(1186):U679. PubMed ID: 14657962
[No Abstract] [Full Text] [Related]
9. Lost in a jungle of evidence: we need a compass.
Pincus MM
Neurology; 2009 Oct; 73(16):1338; author reply 1338-9. PubMed ID: 19841391
[No Abstract] [Full Text] [Related]
10. Sex bias blights drug studies.
Check Hayden E
Nature; 2010 Mar; 464(7287):332-3. PubMed ID: 20237530
[No Abstract] [Full Text] [Related]
11. Eroding precision in scientific communications: contagion from "the real world".
Lyles A
Clin Ther; 2007 Jan; 29(1):182. PubMed ID: 17379059
[No Abstract] [Full Text] [Related]
12. Author's response: the design of observational studies-defining baseline time.
Austin PC; Platt RW
J Clin Epidemiol; 2010 Feb; 63(2):141. PubMed ID: 20122501
[No Abstract] [Full Text] [Related]
13. The powerful placebo.
Harv Mens Health Watch; 2008 Jun; 12(11):4-6. PubMed ID: 18807625
[No Abstract] [Full Text] [Related]
14. [Study designs for the evaluation of drug effects].
Christensen S; Christiansen CF; Sørensen HT
Ugeskr Laeger; 2009 Mar; 171(10):799-802. PubMed ID: 19265605
[TBL] [Abstract][Full Text] [Related]
15. Methodological note: accuracy, precision, and validity.
Ranstam J
Acta Radiol; 2008 Feb; 49(1):105-6. PubMed ID: 18210319
[No Abstract] [Full Text] [Related]
16. [Continuing education. Clinical trials].
Sökeland J
Urologe A; 1990 Nov; 29(6):W41-2. PubMed ID: 2291253
[No Abstract] [Full Text] [Related]
17. Reporting clinical research: an example of balancing a simple clinical message with data required to help future research.
Buckley NA
Emerg Med Australas; 2005 Apr; 17(2):102-3. PubMed ID: 15796722
[No Abstract] [Full Text] [Related]
18. Evaluating homeopathic drugs within a biomedical framework.
Calabrese EJ; Jonas WB
Hum Exp Toxicol; 2010 Jul; 29(7):545-9. PubMed ID: 20558604
[TBL] [Abstract][Full Text] [Related]
19. The concept of placebo.
Szawarski Z
Sci Eng Ethics; 2004 Jan; 10(1):57-64. PubMed ID: 14986772
[TBL] [Abstract][Full Text] [Related]
20. An oncoethical issue.
Cheson BD
Clin Adv Hematol Oncol; 2006 Apr; 4(4):241. PubMed ID: 16779896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
